Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission

This study has been completed.
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
FHI 360
Medical Research Council, South Africa
University of Cape Town
University of Limpopo
United States Agency for International Development (USAID)
Information provided by:
Population Council
ClinicalTrials.gov Identifier:
NCT00213018
First received: September 13, 2005
Last updated: October 21, 2005
Last verified: September 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: January 2002
  Estimated Primary Completion Date: No date given